Muhammad Aslam Selected Research

Multiple Myeloma

1/2022	Outcomes of daratumumab in the treatment of multiple myeloma: A retrospective cohort study from the Canadian Myeloma Research Group Database.
1/2022	Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Report from the Canadian Myeloma Research Group (CMRG) Database.
1/2022	Efficacy of Daratumumab-Containing Regimens Among Patients With Multiple Myeloma Progressing on Lenalidomide Maintenance: Retrospective Analysis.
10/2021	Retrospective study of treatment patterns and outcomes post-lenalidomide for multiple myeloma in Canada.
5/2021	The impact of lenalidomide maintenance on second-line chemotherapy in transplant eligible patients with multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Muhammad Aslam Research Topics

Disease

9	Neoplasms (Cancer) 01/2021 - 11/2008
7	Type 2 Diabetes Mellitus (MODY) 11/2018 - 06/2003
6	Insulin Resistance 11/2018 - 07/2009
5	Multiple Myeloma 01/2022 - 05/2021
5	Pulmonary Hypertension 11/2012 - 01/2009
5	Chronic Hepatitis C 01/2012 - 02/2009
4	Hypoxia (Hypoxemia) 02/2022 - 11/2009
4	Obesity 03/2020 - 07/2012
4	Overweight 03/2020 - 11/2009
4	Urinary Bladder Neoplasms (Bladder Cancer) 02/2012 - 10/2011
3	COVID-19 04/2022 - 08/2020
3	Weight Loss (Weight Reduction) 07/2018 - 11/2009
3	Myocardial Infarction 04/2018 - 06/2017
3	Reperfusion Injury 01/2017 - 09/2006
3	Diabetes Mellitus 12/2015 - 04/2011
3	Multiple Sclerosis 01/2013 - 04/2010
3	Hyperoxia 05/2012 - 12/2009
2	Major Depressive Disorder (Major Depressive Disorders) 12/2022 - 01/2020
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 04/2011
2	Inflammation (Inflammations) 01/2021 - 11/2017
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2017
2	Gastroesophageal Reflux (GERD) 01/2019 - 07/2009
2	Edema (Dropsy) 06/2017 - 09/2006
2	Intellectual Disability (Idiocy) 10/2016 - 08/2014
2	Carcinoma (Carcinomatosis) 10/2011 - 04/2011
2	Hypothyroidism 08/2011 - 01/2010
2	Infections 07/2009 - 03/2005
2	Atherosclerosis 07/2009 - 06/2003
2	Cysts 11/2005 - 11/2003
1	Hypercholesterolemia 02/2022
1	Diffuse Esophageal Spasm (Esophageal Spasm) 01/2022
1	Deglutition Disorders (Dysphagia) 01/2022
1	Muscle Spasticity (Spastic) 01/2022
1	Bipolar Disorder (Manic Depressive Psychosis) 12/2021
1	Mania (Manias) 12/2021
1	Synucleinopathies 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2020
1	Poisoning 12/2019
1	Hepatitis 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019

Drug/Important Bio-Agent (IBA)

7	Insulin (Novolin)FDA Link 11/2018 - 02/2006
6	LipidsIBA 01/2021 - 02/2006
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2010
5	Blood Glucose (Blood Sugar)IBA 11/2018 - 04/2011
4	Biomarkers (Surrogate Marker)IBA 04/2018 - 04/2011
4	Conditioned Culture MediaIBA 11/2012 - 12/2009
4	Ribavirin (Virazole)FDA LinkGeneric 01/2012 - 02/2009
4	Interferon-alpha (Interferon Alfa)IBA 01/2012 - 01/2005
4	InterferonsIBA 10/2011 - 02/2009
3	Lenalidomide (CC 5013)FDA Link 01/2022 - 05/2021
3	Adenosine Triphosphate (ATP)IBA 01/2021 - 09/2006
3	RNA (Ribonucleic Acid)IBA 01/2019 - 04/2009
3	MicroRNAs (MicroRNA)IBA 04/2018 - 11/2012
3	Immunoglobulin G (IgG)IBA 01/2013 - 12/2009
3	AntibodiesIBA 07/2012 - 12/2009
3	Lipoprotein(a)IBA 07/2009 - 06/2003
2	Antidepressive Agents (Antidepressants)IBA 12/2022 - 01/2020
2	Pharmaceutical PreparationsIBA 12/2022 - 01/2021
2	VaccinesIBA 04/2022 - 03/2005
2	CytokinesIBA 02/2022 - 12/2009
2	daratumumabIBA 01/2022 - 01/2022
2	Adenosine (Adenocard)FDA LinkGeneric 01/2021 - 09/2006
2	TubulinIBA 01/2020 - 04/2011
2	ResistinIBA 11/2018 - 05/2015
2	AdiponectinIBA 10/2017 - 05/2015
2	Ribonucleases (Ribonuclease)IBA 06/2017 - 07/2013
2	Thyroglobulin FDA Link 10/2016 - 08/2012
2	AutoantibodiesIBA 07/2012 - 04/2010
2	Keratins (Keratin)IBA 04/2011 - 11/2005
2	Alanine Transaminase (SGPT)IBA 10/2010 - 04/2009
2	oxidized low density lipoproteinIBA 07/2009 - 06/2003
1	Lipid Bilayers (Lipid Bilayer)IBA 02/2022
1	carfilzomibIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Dietary Fats (Dietary Fat)IBA 01/2022
1	pomalidomideIBA 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	LithiumIBA 12/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2021
1	SolutionsIBA 07/2021
1	NucleotidesIBA 01/2021
1	Purinergic Receptors (Receptors, Purine)IBA 01/2021
1	Glucosylceramidase (Glucocerebrosidase)IBA 01/2021
1	Stimuli Responsive PolymersIBA 01/2021
1	LigandsIBA 01/2021
1	Moclobemide (Arima)IBA 08/2020
1	ORALIT (ORS)IBA 03/2020
1	Antipsychotic Agents (Antipsychotics)IBA 01/2020
1	Bupropion (Wellbutrin)FDA LinkGeneric 01/2020
1	Aripiprazole (Abilify)FDA Link 01/2020
1	Methanol (Carbinol)IBA 12/2019

Therapy/Procedure

16	Therapeutics 01/2022 - 02/2006
4	Drug Therapy (Chemotherapy) 05/2021 - 11/2014
2	Catheters 01/2019 - 06/2008
2	Transplantation 01/2017 - 11/2012
2	Caloric Restriction 06/2014 - 11/2009
1	Stem Cell Transplantation 10/2021
1	Electrodes (Electrode) 12/2019
1	Prenatal Care (Care, Prenatal) 01/2019